Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoder
Life Science Alliance · 2024
DOI: 10.26508/lsa.202402674 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Alice Driessen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Data and AI Research, IBM Research Europe, Zürich, Switzerland. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Single-Cell Analysis, Immunophenotyping. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, European Research Council.
Abstract (Originalsprache)
Pediatric acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis and high relapse rate. Current challenges in the identification of immunotherapy targets arise from patient-specific blast immunophenotypes and their change during disease progression. To overcome this, we present a new computational research tool to rapidly identify malignant cells. We generated single-cell flow cytometry profiles of 21 pediatric AML patients with matched samples at diagnosis, remission, and relapse. We coupled a classifier to an autoencoder for anomaly detection and classified malignant blasts with 90% accuracy. Moreover, our method assigns a developmental stage to blasts at the single-cell level, improving current classification approaches based on differentiation of the dominant phenotype. We observed major immunophenotype and developmental stage alterations between diagnosis and relapse. Patients with KMT2A rearrangement had more profound changes in their blast immunophenotypes at relapse compared to patients with other molecular features. Our method provides new insights into the immunophenotypic composition of AML blasts in an unbiased fashion and can help to define immunotherapy targets that might improve personalized AML treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Data and AI Research, IBM Research Europe, Zürich, Switzerland.
- ETH Zürich, Zürich, Switzerland.
- Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
- Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
- Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
ORCID-Profile: Alice Driessen, Susanne Unger, Burkhard Becher, María Rodríguez Martínez
Förderung
- NCI NIH HHS
- European Research Council
Zitieren
APA
Driessen, A., Unger, S., Nguyen, A. P., Ries, R. E., Meshinchi, S., Kreutmair, S., Alberti, C., Sumazin, P., Aplenc, R., Redell, M. S., Becher, B., & Rodríguez Martínez, M. (2024). Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoder. Life Science Alliance. https://doi.org/10.26508/lsa.202402674
Vancouver
Driessen A, Unger S, Nguyen AP, Ries RE, Meshinchi S, Kreutmair S, et al. Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoder. Life Science Alliance. 2024. doi:10.26508/lsa.202402674
BibTeX
@article{Driessen2024,
author = {Driessen, Alice and Unger, Susanne and Nguyen, An-Phi and Ries, Rhonda E and Meshinchi, Soheil and Kreutmair, Stefanie and Alberti, Chiara and Sumazin, Pavel and Aplenc, Richard and Redell, Michele S and Becher, Burkhard and Rodríguez Martínez, María},
title = {Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoder},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202402674}
}
EUVIMED